Dysregulated microRNA targeting of RUFY2 expression was found important for the development of human glioblastoma and ovarian cancer, suggesting a tumor suppression role for RUFY2 (Lukács et al., 2019; Zheng et al., 2020; Figure 4C). Here, RUFY2 is linked to ovarian carcinoma.